Vertex Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $999.2M | $489.4M |
| FY2013 | — | $1.36B | $569.3M |
| FY2014 | — | $1.08B | $625.3M |
| FY2015 | — | $940.0M | $714.8M |
| FY2016 | — | $1.16B | $1.18B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $999.2M | $489.4M |
| FY2013 | — | $1.36B | $569.3M |
| FY2014 | — | $1.08B | $625.3M |
| FY2015 | — | $940.0M | $714.8M |
| FY2016 | — | $1.16B | $1.18B |